Evidence map›Paper›PMID 33806354›Full record

ArticleInternational journal of molecular sciences2021

An Analysis of Differentially Expressed Coding and Long Non-Coding RNAs in Multiple Models of Skeletal Muscle Atrophy.

Keisuke Hitachi, Masashi Nakatani, Yuri Kiyofuji, Hidehito Inagaki, Hiroki Kurahashi, Kunihiro Tsuchida

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Epigenetics of Skeletal Muscle Atrophy.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Characterization of theJournal of clinical medicine · 2022
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Keisuke HitachiDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0002-7300-5238
Masashi NakataniDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake 470-1192, Japan.
Yuri KiyofujiDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake 470-1192, Japan.
Hidehito InagakiGenome and Transcriptome Analysis Center, Fujita Health University, Toyoake 470-1192, Japan.
Hiroki KurahashiGenome and Transcriptome Analysis Center, Fujita Health University, Toyoake 470-1192, Japan.
Kunihiro TsuchidaDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0002-3983-5756
Fujita Health University · JPSeijoh University · JP

Funding

Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP 2-5Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP 29-4Japan Society for the Promotion of Science 19H03427Japan Society for the Promotion of Science 20K07315Mochida Memorial Foundation for Medical and Pharmaceutical Research 2019
6 · The paper itself

Abstract

The loss of skeletal muscle mass (muscle atrophy or wasting) caused by aging, diseases, and injury decreases quality of life, survival rates, and healthy life expectancy in humans. Although long non-coding RNAs (lncRNAs) have been implicated in skeletal muscle formation and differentiation, their precise roles in muscle atrophy remain unclear. In this study, we used RNA-sequencing (RNA-Seq) to examine changes in the expression of lncRNAs in four muscle atrophy conditions (denervation, casting, fasting, and cancer cachexia) in mice. We successfully identified 33 annotated lncRNAs and 18 novel lncRNAs with common expression changes in all four muscle atrophy conditions. Furthermore, an analysis of lncRNA-mRNA correlations revealed that several lncRNAs affected small molecule biosynthetic processes during muscle atrophy. These results provide novel insights into the lncRNA-mediated regulatory mechanism underlying muscle atrophy and may be useful for the identification of promising therapeutic targets.

Indexed as

AnimalsCachexiaDisease Models, AnimalDown-RegulationFastingGene ExpressionHumansMiceMice, Inbred C57BLMuscle DenervationMuscle, SkeletalMuscular AtrophyRestraint, PhysicalRNA, Long NoncodingRNA, MessengerRNA-SeqRNA, Long NoncodingRNA, Messengerlong non-coding RNAmRNARNA-sequencingskeletal muscle atrophy

Identifiers

PMID33806354
PMCPMC7961583
OpenAlexW3135084296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.